1 Min Read
May 28 (Reuters) - Medigene AG :
* U.S. patent office prolongs term of Medigene’s patent relating to dendritic cell (DC) vaccines to 2031 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.